LAMATTINA JOHN L — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

LAMATTINA JOHN L has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.88M.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-12LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale3.4K$251.62$857K
2026-06-12LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale697$249.53$174K
2026-06-12LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale232$248.11$58K
2026-06-12LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale257$247.22$64K
2026-06-09LGNDLIGAND PHARMACEUTICALS INCA — Grant or award836$0.00
2026-03-31LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale2.2K$200.76$434K
2026-03-31LGNDLIGAND PHARMACEUTICALS INCM — Option exercise2.2K$114.15$247K
2025-06-06LGNDLIGAND PHARMACEUTICALS INCA — Grant or award1.2K$0.00
2024-12-02LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale2.4K$123.65$298K
2024-12-02LGNDLIGAND PHARMACEUTICALS INCM — Option exercise2.4K$52.30$126K

Companies — Last 90 Days

Frequently Asked Questions

Who is LAMATTINA JOHN L?

LAMATTINA JOHN L is a corporate insider — currently tracked as Director of LIGAND PHARMACEUTICALS INC (LGND). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has LAMATTINA JOHN L submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has LAMATTINA JOHN L been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 6 open-market sales ($1.88M) across all tracked filings.

Where can I see all of LAMATTINA JOHN L's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live LAMATTINA JOHN L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.